US Markets
BHC

Bausch Health agrees to pay $45 mln to settle U.S. charges of misleading disclosures

Canada-based Bausch Health Companies Inc has agreed to pay a $45 million penalty to settle charges of improper revenue recognition and misleading disclosures in Securities and Exchange Commission filings and earnings presentations, the SEC said on Friday.

WASHINGTON, July 31 (Reuters) - Canada-based Bausch Health Companies Inc has agreed to pay a $45 million penalty to settle charges of improper revenue recognition and misleading disclosures in Securities and Exchange Commission filings and earnings presentations, the SEC said on Friday.

Three former executives, including the chief executive officer of the company, formerly Valeant Pharmaceuticals, also agreed to pay penalties to settle charges against them, the SEC said. (Reporting by Tim Ahmann; Writing by Mohammad Zargham;) ((mohammad.zargham@thomsonreuters.com;)) Keywords: BAUSCH HEALTH USA/SETTLEMENT (URGENT)

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

BHC

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More